Nuvation Bio Class A financial statements
누베이션 바이오NYSE:NUVB · New York Stock Exchange · Healthcare · sector #17$4.86-0.41%
2026-10-07 closeNuvation Bio Class A's published financial data is dated 2026-10-04. 2024 revenue was $8M. 2024 operating profit was −$593M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy